Spots Global Cancer Trial Database for retrospective
Every month we try and update this database with for retrospective cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast Cancer | NCT04857619 | Metastatic Brea... | None (Observati... | - | AstraZeneca | |
| A Study to Record in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any Procedure | NCT01241396 | Multiple Myelom... | Any MMY treatme... | 18 Years - 99 Years | Janssen Pharmaceutica N.V., Belgium | |
| Study to Evaluate Clinical Real World Outcomes of Lorlatinib After Alectinib in ALK-Positive NSCLC Japanese Patients | NCT04979988 | ALK-positive No... | Lortlatinib | 20 Years - | Pfizer | |
| National Wide Cross-sectional Study in Paediatric Central Nervous System Tumours in China -- the CNOG-MC001 Registry | NCT04351035 | Tumors, Central... Pediatric Brain... Malignant Brain... Benign Brain Tu... | Tumour resectio... | - 18 Years | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | |
| A Study of Effectiveness and Safety of the First-Line Nivolumab Plus Ipilimumab With or Without Chemotherapy for Advanced/Recurrent Non-Small Cell Lung Cancer in Japan | NCT05161325 | Non-Small Cell ... | 20 Years - | Bristol-Myers Squibb | ||
| Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART) | NCT05012865 | Renal Cell Carc... | avelumab axitinib | 20 Years - | Pfizer | |
| A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands | NCT02546375 | Chronic Myeloid... | Bosutinib | 18 Years - | Pfizer | |
| Prediction Models for Complications After CRT in Esophageal Cancer | NCT06366828 | The Aim of This... | retrospective | 18 Years - 100 Years | University Medical Center Groningen | |
| Retrospective, External Comparator Study of Lazertinib as the 2nd-Line Treatment in Patients With EGFR Mutation+ NSCLC | NCT05862194 | Non-small Cell ... | Lazertinib Platinum-based ... | 18 Years - | Yuhan Corporation | |
| Umbrella Study for Analysis of Data Related to Patients With Cancer | NCT06018753 | Cancer | - | Tempus AI | ||
| Treatment Patterns, Outcomes and Testing in EGFRm NSCLC Patients With EGFR TKI 1L Across Europe (REFLECT) | NCT04031898 | Lung Cancer | Non Interventio... | - | AstraZeneca | |
| Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan | NCT05399329 | Breast Cancer | Palbociclib Endocrine thera... | 20 Years - | Pfizer | |
| Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma | NCT05986682 | Multiple Myelom... | Blenrep | 18 Years - 89 Years | Duke University | |
| Role of Gene Variation in Effectiveness of Gleevec Treatment | NCT00342056 | Cancer Breast Cancer | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Spanish Registry of Erythropoietic Stimulating Agents Study | NCT01739452 | Myelodysplastic... | 18 Years - | Grupo Español de Síndromes Mielodisplásicos | ||
| A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms | NCT02842229 | Myelodysplastic... Leukemia Myeloi... Multiple Myelom... Leukemia, Lymph... | 65 Years - | Celgene | ||
| Treatment Patterns, Outcomes and Testing in EGFRm NSCLC Patients With EGFR TKI 1L Across Europe (REFLECT) | NCT04031898 | Lung Cancer | Non Interventio... | - | AstraZeneca | |
| Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture | NCT05877066 | Dupuytren's Con... | 18 Years - | Endo Pharmaceuticals | ||
| Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice | NCT02655159 | Breast Neoplasm... | 18 Years - | Celgene Corporation | ||
| Azilect + Antidepressant Chart Review | NCT00955604 | Serotonin Syndr... | Group R+AD Rasa... Group R Rasagil... Group AD Anti-P... | - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2) | NCT05650164 | Renal Cell Carc... | avelumab axitinib | 18 Years - | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | |
| A Chart Review Study of Adults With Advanced NSCLC | NCT05207423 | Non-small Cell ... | 18 Years - | Takeda | ||
| Analysis of the Results of Treatment for Cervical Carcinoma in Limburg | NCT01059695 | Cervical Cancer | - | Maastricht Radiation Oncology | ||
| Azilect + Antidepressant Chart Review | NCT00955604 | Serotonin Syndr... | Group R+AD Rasa... Group R Rasagil... Group AD Anti-P... | - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib | NCT01459757 | GIST | non-interventio... | 18 Years - | Pfizer | |
| Phenotyping Liver Cancer Registry | NCT04681274 | Hepatocellular ... | Image features ... Phenotype signa... | 18 Years - 100 Years | Assistance Publique - Hôpitaux de Paris | |
| Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Tyrosine Kinase-3 (FLT3) Mutation Study Based on Retrospective Chart Review | NCT03047083 | Acute Myeloid L... | Treatment patte... AML-related hea... | 18 Years - | Astellas Pharma Inc | |
| National Wide Cross-sectional Study in Paediatric Central Nervous System Tumours in China -- the CNOG-MC001 Registry | NCT04351035 | Tumors, Central... Pediatric Brain... Malignant Brain... Benign Brain Tu... | Tumour resectio... | - 18 Years | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | |
| Incidence and Mortality of Childhood Cancer Among Children of Farmer Pesticide Applications | NCT00339378 | Pesticide Expos... | - | National Institutes of Health Clinical Center (CC) | ||
| Analysis of the Results of Treatment for Cervical Carcinoma in Limburg | NCT01059695 | Cervical Cancer | - | Maastricht Radiation Oncology | ||
| Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan | NCT05399329 | Breast Cancer | Palbociclib Endocrine thera... | 20 Years - | Pfizer | |
| Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study). | NCT05534789 | Carcinoma, Rena... | 18 Years - | Pfizer | ||
| Azilect + Antidepressant Chart Review | NCT00955604 | Serotonin Syndr... | Group R+AD Rasa... Group R Rasagil... Group AD Anti-P... | - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Azilect + Antidepressant Chart Review | NCT00955604 | Serotonin Syndr... | Group R+AD Rasa... Group R Rasagil... Group AD Anti-P... | - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2) | NCT05650164 | Renal Cell Carc... | avelumab axitinib | 18 Years - | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | |
| A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread | NCT05431777 | Urothelial Carc... | Avelumab | 0 Years - | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | |
| Rapid Learning for Lung Cancer | NCT01949259 | Lung Cancer | - | Maastricht Radiation Oncology | ||
| A Non-Interventional Follow-Up to the VELOUR Study - Translational Research | NCT01754272 | Metastatic Colo... | 18 Years - | KU Leuven | ||
| A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms | NCT02842229 | Myelodysplastic... Leukemia Myeloi... Multiple Myelom... Leukemia, Lymph... | 65 Years - | Celgene | ||
| Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study). | NCT05534789 | Carcinoma, Rena... | 18 Years - | Pfizer | ||
| A Study of Effectiveness and Safety of the First-Line Nivolumab Plus Ipilimumab With or Without Chemotherapy for Advanced/Recurrent Non-Small Cell Lung Cancer in Japan | NCT05161325 | Non-Small Cell ... | 20 Years - | Bristol-Myers Squibb | ||
| Rapid Learning for Lung Cancer | NCT01949259 | Lung Cancer | - | Maastricht Radiation Oncology | ||
| A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms | NCT02842229 | Myelodysplastic... Leukemia Myeloi... Multiple Myelom... Leukemia, Lymph... | 65 Years - | Celgene | ||
| Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2) | NCT05650164 | Renal Cell Carc... | avelumab axitinib | 18 Years - | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | |
| Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture | NCT05877066 | Dupuytren's Con... | 18 Years - | Endo Pharmaceuticals | ||
| A Study to Record in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any Procedure | NCT01241396 | Multiple Myelom... | Any MMY treatme... | 18 Years - 99 Years | Janssen Pharmaceutica N.V., Belgium | |
| Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland | NCT05363488 | Myeloid Leukemi... | Bosutinib | 18 Years - | Pfizer |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
